TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination (original) (raw)

References

  1. Raine, C.S. The immunology of the multiple sclerosis lesion [The Dale E. McFarlin memorial lecture]. Ann. Neurol. 36, S61–S72 (1994).
    Article CAS Google Scholar
  2. Bernard, C.C.A. & Kerlero de Rosbo, N. Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr. Opin. Cell Biol. 4, 760–765 (1992).
    Article CAS Google Scholar
  3. Merrill, J.E. & Benveniste, E.N. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci. 19, 331–338 (1996).
    Article CAS Google Scholar
  4. Navikas, V. & Link, H. Cytokines and the pathogenesis of multiple sclerosis [Review]. J. Neurosci. Res. 45, 322–333 (1996).
    Article CAS Google Scholar
  5. Selmaj, K., Papierz, W., Glabinski, A. & Kohno, T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56, 135–141 (1995).
    Article CAS Google Scholar
  6. Bernard, C.C.A., et al. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75, 77–88 (1997).
    Article CAS Google Scholar
  7. Marino, M.W., et al. Characterization of tumor necrosis factor deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093–8098 (1997).
    Article CAS Google Scholar
  8. Aggarwal, B.B. & Natarajan, K. Tumor necrosis factor: Developments during the last decade. Eur. Cytokine Netw. 7; 93–124 (1996).
    CAS PubMed Google Scholar
  9. Ruddle, N.H. et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172, 1193–1200 (1990).
    Article CAS Google Scholar
  10. Willenborg, D.O., Fordham, S., Bernard, C.C.A., Cowden, W.B. & Ramshaw, I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocy glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223–3227 (1996).
    CAS PubMed Google Scholar
  11. Ichikawa, M., Johns, T.G., Liu, J. & Bernard, C.C.A. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35–55. J. Immunol. 157, 919–926 (1996).
    CAS PubMed Google Scholar
  12. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397–1411 (1996).
    Article CAS Google Scholar
  13. Linington, C., et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23, 1364–1371 (1993).
    Article CAS Google Scholar
  14. Sercarz, E.E., et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11, 729–766 (1993).
    Article CAS Google Scholar
  15. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. & Brosnan, C.F. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522–1529 (1991).
    CAS PubMed Google Scholar
  16. Sharief, M.K. & Hentges, R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467–472 (1991).
    Article CAS Google Scholar
  17. Paya, C.V., Leibson, P.J., Patrick, A.K. & Rodriguez, M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor-α. Int. Immunol. 2, 909–913 (1990).
    Article CAS Google Scholar
  18. Jacob, C.O. & McDevitt, H.O. Tumour necrosis factor-α in murine autoimmune ‘lupus’ nephritis. Nature, 331, 356–358 (1988).
    Article CAS Google Scholar
  19. Jacob, C.O., Aiso, S., Michie, S.A., McDevitt, H.O. & Acha-Orbea, H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87, 968–972 (1990).
    Article CAS Google Scholar
  20. Bruce, A.J., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2, 788–794 (1996).
    Article CAS Google Scholar
  21. Rothwell, N.J. & Luheshi, G.N. Brain TNF: Damage limitation or damaged reputation? Nature Med. 2, 746–747 (1996).
    Article CAS Google Scholar
  22. Liu, Z., Hsu, H., Goeddel, D.V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565–576 (1996).
    Article CAS Google Scholar
  23. Eugster, H-P., et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8, 23–36 (1996).
    Article CAS Google Scholar
  24. Lewis, M., et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88, 2830–2834 (1991).
    Article CAS Google Scholar
  25. Vanoosten, B.W., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody CA2. Neurology 47, 1531–1534 (1996).
    Article CAS Google Scholar
  26. Jayaram, B.M., Menon, K.K., Slavin, A., Reid, H. & Bernard, C.C.A. Purification of human myelin oligodendrocyte glycoprotein (MOG) produced in bacteria and Sf9 insect cells [Abstr.]. J. Neurochem. 66, S41 (1996).
    Google Scholar

Download references